Sema4

We have announced new research highlighting the importance of rapid sequencing for diseases in the . Our study underscores the opportunity to improve health outcomes for critically ill newborns with early medical intervention. Learn more: https://hubs.la/Q01t-rQx0.

LabPulse.com featured our recent collaboration with Massachusetts General Hospital on new research demonstrating & sequencing deliver more diagnostic certainty than multi-gene panels. Read more: https://hubs.la/Q01sBT8Y0.

Sema4|GeneDx announces collaborative study results for effectiveness of genome and exome sequencing In the study, genomic tests reported 30% fewer inconclusive results compared to multi-gene panel tests (23% vs. 33%) and a higher diagnostic yield (18% vs. 10%)